- 18F|Fluciclovine PET metabolic imaging reveals prostate cancer ...🔍
- Update on 18F|Fluciclovine PET for Prostate Cancer Imaging🔍
- 18F|Fluciclovine PET/CT performance in biochemical recurrence of ...🔍
- Clinical|Prostate cancer Impact of 18 F|fluciclovine PET/CT on plans ...🔍
- Prostate Cancer Imaging with 18F|Fluciclovine🔍
- Imaging of Prostate Cancer Using Fluciclovine🔍
- Detection of Additional Primary Neoplasms on 18F|Fluciclovine PET ...🔍
- 18 F|Fluciclovine versus PSMA PET Imaging in Primary Tumor ...🔍
18F|Fluciclovine PET metabolic imaging reveals prostate cancer ...
18F-Fluciclovine PET metabolic imaging reveals prostate cancer ...
18 F-Fluciclovine uptakes highlight tumour heterogeneity that may explain castration resistance and can be exploited as a clinical biomarker.
18F-Fluciclovine PET metabolic imaging reveals prostate cancer ...
F-Fluciclovine (or 18F-FACBC) is a synthetic L-leucine analogue taken up by cells via amino acid transporters (AATs), with the LAT1 and ASCT2 ...
Update on 18F-Fluciclovine PET for Prostate Cancer Imaging
PET is a functional imaging method that can exploit various aspects of tumor biology to enable greater detection of prostate cancer than can ...
18F-Fluciclovine PET/CT performance in biochemical recurrence of ...
F-Fluciclovine PET/CT shows good performance in patients with recurrent prostate cancer leading to measurable clinical benefits. Careful ...
Clinical-Prostate cancer Impact of 18 F-fluciclovine PET/CT on plans ...
F-Fluciclovine detected lesions in 85 of 146 (58%) patients planned for ADT. Detection rates in the prostate/bed, pelvic LN, extra-pelvic LN, soft tissues and ...
Prostate Cancer Imaging with 18F-Fluciclovine - PET Clinics
18F-Fluciclovine PET/computed tomography is the Food and Drug Administration approved for the localization of recurrent prostate cancer. Keywords. FACBC ...
Imaging of Prostate Cancer Using Fluciclovine
FACBC Fluciclovine Axumin CT PET Prostate. KEY POINTS. Functional molecular imaging with PET improves the ability to detect prostate cancer. Fluciclovine is ...
Detection of Additional Primary Neoplasms on 18F-Fluciclovine PET ...
Overall, 55 (9.1%) of 601 prostate cancer patients who underwent 18F-fluciclovine PET/CT had a second neoplasm (48, malignant; 7, benign) ...
18 F-Fluciclovine versus PSMA PET Imaging in Primary Tumor ...
In patients with high-risk prostate cancer, prostate-specific membrane antigen (PSMA) PET revealed a pooled sensitivity of 84% (95% CI: 77%, 89 ...
18F-Fluciclovine PET for Assessment of Prostate Cancer with ...
In the past, the role of PET for prostate cancer imaging has been limited. However, in recent years, several new PET tracers have emerged that offer improved ...
Diagnostic Performance of PET/CT Using 18F-FACBC in Prostate ...
18F-FACBC is a synthetic amino acid that is not metabolized or incorporated into proteins. It shows increased flow into tumor cells via amino ...
Letter regarding “ 18 F-Fluciclovine PET/CT performance in ... - Nature
The authors found that the detection rate of metastatic lesions with 18 F-fluciclovine PET was overall correlative to prostate-specific antigen (PSA) levels.
Simultaneous 18 F-fluciclovine Positron Emission Tomography and ...
Several studies have investigated the performance of 18F-fluciclovine PET in prostate cancer, demonstrating that the tracer uptake is significantly higher in ...
PSMA PET-CT Accurately Detects Prostate Cancer Spread - NCI
For men with localized prostate cancer at high risk of spreading, results from a large clinical trial show an imaging method known as PSMA ...
Fluorine-18-Labeled Fluciclovine PET/CT in Primary and ...
Prostate cancer has been found to overex-press many amino acid transporter systems, making 18F-fluciclovine a promising imaging agent for evaluation of this ...
Review of 18 F-Fluciclovine PET for Detection of Recurrent Prostate ...
In 2016, the U.S. Food and Drug Administration found the accuracy of FACBC PET to be superior to that of other molecular imaging techniques and ...
PSMA PET Scan for Prostate Cancer | UCSF Radiology
The new prostate-specific membrane antigen (PSMA) PET imaging will significantly improve how prostate cancer is detected and treated.
(PDF) 18F-Fluciclovine PET metabolic imaging reveals prostate ...
Castrated mice bearing CWR22Res and 22Rv1 orthografts mimic clinical prostate cancer following acute and chronic ADT, respectively. ¹⁸F-Fluciclovine (1-amino-3- ...
18F-Fluciclovine PET metabolic imaging reveals prostate cancer ...
We studied in vivo 18F-Fluciclovine uptake in human prostate cancer orthograft models following acute and chronic ADT. ... F-Fluciclovine uptakes highlight tumour ...
18F-Fluciclovine PET metabolic imaging reveals prostate cancer ...
Prostate cancer is highly prevalent worldwide. Androgen deprivation therapy (ADT) remains the treatment of choice for incurable prostate cancer, ...